Somerset, N.J. – January 14, 2016 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, and a leader in global clinical supply services, today announced that Ms. Dianne Coughlan, Global Director, Supply Chain Effectiveness, will be presenting at the upcoming Clinical Trials Supply Europe Conference, to be held at the Husa President Park, Brussels, Belgium, on January 19th – 21st, 2016.
Ms. Coughlan’s presentation, on Wednesday, January 20th at 1.30 p.m., is entitled “Lean and Regional: A Novel Approach to Improving Supply Chain Efficiency in Global Studies”, and will discuss how the traditional supply-led approach to clinical trials presents challenges including long lead times, and inflexibility when study plans change. These factors can potentially lead to inventory issues and can compromise the trial, and even put patients at risk through stock-outs. Ms. Coughlan will go on to introduce and explain the benefits of a demand-led supply model, which decouples primary packaging from secondary packaging and labelling activities, allowing the final stages to take place at regional or country levels, thereby reducing lead times and optimizing inventory management.
Ms. Coughlan joined Catalent in 2007 and is based at the company’s Bathgate facility near Edinburgh, Scotland. Her responsibilities include leading the development of standard supply chain tools that drive effectiveness in planning, Materials Requirements Planning (MRP), and logistics. Her role also includes the deployment of a common system template, improved processes and advanced technology to drive continuous improvement in planning, scheduling, purchasing and supply chain logistics. Ms. Coughlan holds a Diploma in Business Management from The University of West Scotland and is a Black Belt in Lean Six Sigma.
For more information on the Clinical Trials Supply Europe Conference, visit: http://www.clinicalsupplyeurope.com and to arrange a meeting with Ms. Coughlan, contact Richard Kerns at NEPR- richard(at)nepr.eu.
+44 (0)7580 041073
+44 (0) 161 728 5880
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health and animal health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,700 people, including over 1,000 scientists, at 31 facilities across 5 continents, and in fiscal 2015 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit www.catalent.com